Manchester Capital Management’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.07K | Hold |
540
| – | – | ﹤0.01% | 901 |
|
|
2025
Q1 | $3.84K | Hold |
540
| – | – | ﹤0.01% | 934 |
|
|
2024
Q4 | $6.3K | Hold |
540
| – | – | ﹤0.01% | 865 |
|
|
2024
Q3 | $11.1K | Hold |
540
| – | – | ﹤0.01% | 775 |
|
|
2024
Q2 | $12.1K | Buy |
+540
| New | +$12.1K | ﹤0.01% | 728 |
|
|
2023
Q4 | – | Sell |
-2,000
| Closed | -$63.2K | – | 1051 |
|
|
2023
Q3 | $63.2K | Hold |
2,000
| – | – | 0.01% | 390 |
|
|
2023
Q2 | $81.6K | Hold |
2,000
| – | – | 0.01% | 369 |
|
|
2023
Q1 | $74.5K | Hold |
2,000
| – | – | 0.01% | 383 |
|
|
2022
Q4 | $69.8K | Hold |
2,000
| – | – | 0.01% | 354 |
|
|
2022
Q3 | $112K | Hold |
2,000
| – | – | 0.02% | 271 |
|
|
2022
Q2 | $104K | Hold |
2,000
| – | – | 0.02% | 295 |
|
|
2022
Q1 | $145K | Sell |
2,000
-104
| -5% | -$7.54K | 0.02% | 286 |
|
|
2021
Q4 | $249K | Hold |
2,104
| – | – | 0.03% | 239 |
|
|
2021
Q3 | $282K | Buy |
+2,104
| New | +$282K | 0.04% | 242 |
|